You are here

  • Home
  • Archive
  • Volume 15, Issue 3
  • Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause

Alerts

Article menu
Download PDFPDF
Therapeutics
Women's Health Initiative randomised ontrolled trial
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address